share_log

三葉草生物-B：股東週年大會適用的代表委任表格

CLOVER BIO-B: Form of Proxy for Use at Annual General Meeting

Hong Kong Stock Exchange ·  Apr 25 07:46
Summary by Moomoo AI
三葉草生物-B（股份代號：2197）將於2024年6月20日舉行股東週年大會，地點為中國（四川）自由貿易試驗區成都高新區。大會將審議包括採納2023年度經審核財務報表、董事及核數師報告，以及重選董事等事項。此外，將授權董事會釐定董事酬金，續聘安永會計師事務所為核數師，並授權董事發行及購回股份。股東將通過委任代表表格指定代表出席大會並投票。大會通告及相關文件已於2024年4月26日發布。
三葉草生物-B（股份代號：2197）將於2024年6月20日舉行股東週年大會，地點為中國（四川）自由貿易試驗區成都高新區。大會將審議包括採納2023年度經審核財務報表、董事及核數師報告，以及重選董事等事項。此外，將授權董事會釐定董事酬金，續聘安永會計師事務所為核數師，並授權董事發行及購回股份。股東將通過委任代表表格指定代表出席大會並投票。大會通告及相關文件已於2024年4月26日發布。
Clover Bio-B (stock code: 2197) will be held on June 20, 2024 at the Chengdu High-tech Zone, China (Sichuan) Pilot Free Trade Zone. The deliberations will include adoption of audited financial statements for 2023, reports of directors and auditors, and re-election of directors. In addition, the Board of Directors will be authorized to determine the remuneration of directors, to renew EY as auditor, and to authorize the directors to issue and repurchase shares. Shareholders will appoint representatives to attend and vote at the General Meeting by means of a Proxy Form. The General Meeting Notice and related documents were published on 26 April 2024.
Clover Bio-B (stock code: 2197) will be held on June 20, 2024 at the Chengdu High-tech Zone, China (Sichuan) Pilot Free Trade Zone. The deliberations will include adoption of audited financial statements for 2023, reports of directors and auditors, and re-election of directors. In addition, the Board of Directors will be authorized to determine the remuneration of directors, to renew EY as auditor, and to authorize the directors to issue and repurchase shares. Shareholders will appoint representatives to attend and vote at the General Meeting by means of a Proxy Form. The General Meeting Notice and related documents were published on 26 April 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more